Endofluke

1 x 2,5 l

Suspension

Active substance

Triclabendazole : 100 mg/ml

ATC code

QP52AC01 Triclabendazole

QP52AC Benzimidazoles and related substances

QP52A Anthelmintics

QP52 Anthelmintics

QP Antiparasitic products, insecticides and repellents

Species

Cattle and sheep.

Indications

For the treatment of adult, immature and early immature stages of liver fluke (Fasciola hepatica) susceptible to triclabendazole.

Dose to be administered and administration route

Oral use.

For single oral administration only.

The use of suitably calibrated dosing equipment is recommended.

The veterinary medicinal product is suitable for most types of automatic drenching guns.

Shake the container before use.

Use unaltered from original container.

Clean drenching equipment before and after use.

Dosage:

Cattle: The recommended dose rate is 12 mg triclabendazole per kg bodyweight.

Sheep: The recommended dose rate is 10 mg triclabendazole per kg bodyweight.

Practical Dosage Guide:

Cattle: 6 ml per 50 kg bodyweight

Animal Weight		Dose of Product
50 kg	6 ml
100 kg	12 ml
150 kg	18 ml
200 kg	24 ml
250 kg	30 ml
300 kg	36 ml
350 kg	42 ml
400 kg	48 ml
For each additional 50 kg	6 ml

Sheep: 1 ml per 10 kg bodyweight

Animal Weight		Dose of Product
10 kg	1 ml
20 kg	2 ml
30 kg	3 ml
40 kg	4 ml
50 kg	5 ml
60 kg	6 ml
For each additional 10 kg	1 ml

Underdosing could result in ineffective use and may favour resistance development.

To ensure a correct dosage, body weight should be determined as accurately as possible.

Accuracy of the dosing device should be thoroughly checked.

If animals are to be treated collectively rather than individually, they should be grouped according to their bodyweight and dosed accordingly, in order to avoid under- or overdosing.

For infestations with Fasciola hepatica, the need for and frequency of re-treatment(s) should be based on professional advice and should take into account the local epidemiological situation and the animal’s lifecycle.

To avoid the potential for the accumulation of residues following repeat administration of the veterinary medicinal product; animals should not be treated with a frequency of less than 10 weeks.

Adverse reactions

Cattle:

Undetermined frequency (cannot be estimated from the available data)

Skin inflammation¹

¹Occasionally, of the unpigmented skin, including the udder and the teats may occur after treatment in cattle exposed to intense sunshine.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.